ZC4H2-Associated Rare Disorders

Add links
From Wikipedia, the free encyclopedia
(Redirected from ZC4H2 deficiency)

ZC4H2 (Zinc finger Cys4His2-type) is a protein-coding gene located on the X-chromosome. This gene encodes a protein which is a member of the so-called zinc finger domain-containing protein family. There is currently very limited understanding about the ZC4H2 gene and its protein function.

Pathogenic variants of ZC4H2 which are associated with a clinical phenotype are referred to as "ZC4H2-Associated Rare Disorders".[a]

The limited research published to date indicates that ZC4H2 is expressed at various developmental stages and is subject to X-inactivation in females. There are a few families and singletons (males and females) with pathogenic variants of ZC4H2 described in the medical literature.[4][5][6][7][8][9] In the families the variants can be transmitted as an X-linked recessive trait, which means that the disorder is fully expressed predominantly in males, while their carrier female siblings are unaffected or much less severely affected. In contrast to these females, heterozygous de novo variants in ZC4H2 in singleton females can result in a specific phenotype.

The pathogenic variants of ZC4H2 may result in impairment of the central and peripheral nervous system through the impairment of neurologic development or synaptic plasticity.[4] Studies in zebrafish showed that the homologue of human ZC4H2 is associated with the generation of a specific subset of central nervous system interneurons.[5]

Besides the cases described in the current literature, an additional 46 diagnosed cases of males and females with ZC4H2 deficiency are known worldwide, constituting this an ultra-rare orphan disorder.

Phenotypes[edit]

There is no clear prediction of the phenotypic expression but it is known that the disorder can be fully expressed in males, while the clinical presentation in singleton females who have a de novo variant can be very variable.

Patients with this condition can have several disabilities and health concerns, including a large array of neuromuscular and neurological manifestations. These can include:

To date, there is no cure or effective treatment for this condition, but a correlation has been observed between early therapeutic interventions and more favorable outcomes. The current approach consists of supportive therapies and medical interventions, including surgery to alleviate specific malformations.[3]

Notes[edit]

  1. ^ The expression of the ZC4H2 mutation is referred by some as "Wieacker-Wolff Syndrome"[1] in other publications appearing as "Miles-Carpenter Syndrome".[2] These nomenclatures describe the phenotypes observed in some individuals with a deleterious mutation on the ZC4H2 gene but they do not accurately define the highly varied clinical presentations found among the affected population. Therefore the National Organization for Rare Disorders (NORD) refers to by its cause, as ZC4H2-Associated Rare Disorders (ZARD).[3]

References[edit]

  1. ^ Wieacker, Peter; Wolff, Gerhard; Wienker, Thomas F.; et al. (1985). "A new X-linked syndrome with muscle atrophy, congenital contractures, and oculomotor apraxia". American Journal of Medical Genetics. 20 (4). Wiley: 597–606. doi:10.1002/ajmg.1320200405. ISSN 0148-7299. PMID 4039531.
  2. ^ Miles, Judith H.; Carpenter, Nancy J. (1991-02-01). "Unique X-linked mental retardation syndrome with fingertip arches and contractures linked to Xq21.31". American Journal of Medical Genetics. 38 (2–3). Wiley: 215–223. doi:10.1002/ajmg.1320380209. ISSN 0148-7299. PMID 2018061.
  3. ^ a b "ZC4H2-Associated Rare Disorders (ZARD)". National Organization for Rare Disorders (NORD). September 22, 2022. Retrieved February 12, 2023.
  4. ^ a b Hirata, Hiromi; Nanda, Indrajit; van Riesen, Anne; et al. (2013). "ZC4H2 Mutations Are Associated with Arthrogryposis Multiplex Congenita and Intellectual Disability through Impairment of Central and Peripheral Synaptic Plasticity". The American Journal of Human Genetics. 92 (5). Elsevier BV: 681–695. doi:10.1016/j.ajhg.2013.03.021. ISSN 0002-9297. PMC 3644645. PMID 23623388.
  5. ^ a b May, Melanie; Hwang, Kyu-Seok; Miles, Judith; et al. (2015-06-08). "ZC4H2, an XLID gene, is required for the generation of a specific subset of CNS interneurons". Human Molecular Genetics. 24 (17). Oxford University Press (OUP): 4848–4861. doi:10.1093/hmg/ddv208. ISSN 0964-6906. PMC 4527488. PMID 26056227.
  6. ^ Zanzottera, Cristina; Milani, Donatella; Alfei, Enrico; et al. (2017-03-27). "ZC4H2 deletions can cause severe phenotype in female carriers". American Journal of Medical Genetics Part A. 173 (5). Wiley: 1358–1363. doi:10.1002/ajmg.a.38155. ISSN 1552-4825. PMID 28345801. S2CID 8505583.
  7. ^ Godfrey, Natalie D.; Dowlatshahi, Samandar; Martin, Madelena M.; Rothkopf, Douglas M. (2017-11-17). "Wieacker-Wolff syndrome with associated cleft palate in a female case". American Journal of Medical Genetics Part A. 176 (1). Wiley: 167–170. doi:10.1002/ajmg.a.38527. ISSN 1552-4825. PMID 29150902. S2CID 40056722.
  8. ^ Okubo, Yukimune; Endo, Wakaba; Inui, Takehiko; et al. (2018). "A severe female case of arthrogryposis multiplex congenita with brain atrophy, spastic quadriplegia and intellectual disability caused by ZC4H2 mutation". Brain and Development. 40 (4). Elsevier BV: 334–338. doi:10.1016/j.braindev.2017.11.011. ISSN 0387-7604. PMID 29254829. S2CID 3693309.
  9. ^ Kondo, Daiki; Noguchi, Atsuko; Takahashi, Ikuko; et al. (2018). "A novel ZC4H2 gene mutation, K209N, in Japanese siblings with arthrogryposis multiplex congenita and intellectual disability: characterization of the K209N mutation and clinical findings". Brain and Development. 40 (9). Elsevier BV: 760–767. doi:10.1016/j.braindev.2018.05.003. ISSN 0387-7604. PMID 29803542. S2CID 44085202.
Retrieved from "https://en.wikipedia.org/w/index.php?title=ZC4H2-Associated_Rare_Disorders&oldid=1140180021"